Adaptimmune Therapeutics PLC

Last updated September 28, 2026
Favorite this organization

Organization details

Legal name
Adaptimmune Therapeutics PLC
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
72110 - Research and experimental development on biotechnology
Year founded
2014
Jurisdiction of incorporation
England and Wales
Headquarters city
Abingdon
Headquarters country
United Kingdom
Fiscal year end
December

Identifiers

UK company number
09338148

Board of directors

Follow this board

Former directors

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

Akanda Corp. Nasdaq: AKAN · New Romney, United Kingdom Akari Therapeutics plc Nasdaq: AKTX · Tampa, United Kingdom AstraZeneca PLC NYSE: AZN · Cambridge, United Kingdom Autolus Therapeutics plc American Depositary Share Nasdaq: AUTL · London, United Kingdom

Questions about Adaptimmune Therapeutics PLC

How many directors are on Adaptimmune Therapeutics PLC's board?

Adaptimmune Therapeutics PLC's board has 3 directors: Christopher James Hill, Garry Edward, Menzel and Lawrence Michael Alleva.

How is Adaptimmune Therapeutics PLC connected to…? → Spot something wrong? Report a correction
Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here. 

<div data-bod-board="adaptimmune-therapeutics-plc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.